---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-045016"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T06:54:36.807926+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuwellis reports preliminary Q3 revenue ~$2.4M, gross margin 70%, cash $1.9M

## Summary
- Revenue of approximately $2.4 million; pediatric category grew 28% YoY.
- Gross margin improved to 70% from 57.3% YoY; operating costs fell ~30%.
- Cash used in ops ~$2.5M; cash and equivalents ~$1.9M at quarter end.
- SeaStar settlement: $900K aggregate due by Dec 31, 2024; ~$500K received.
- Full Q3 results and earnings call scheduled for November 11, 2024.

## SEC filing metadata
- accession: 0001140361-24-045016
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036124045016/0001140361-24-045016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036124045016/ef20037953_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-045016
- JSON: https://secwatch.observer/filing/0001140361-24-045016.json
- Plain text: https://secwatch.observer/filing/0001140361-24-045016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.